PMID- 18831904
OWN - NLM
STAT- MEDLINE
DCOM- 20081027
LR  - 20191210
IS  - 0300-0605 (Print)
IS  - 0300-0605 (Linking)
VI  - 36
IP  - 5
DP  - 2008 Sep-Oct
TI  - The Angio-Seal arterial closure device for early ambulation after elective 
      percutaneous coronary intervention in patients receiving low-dose enoxaparin.
PG  - 1077-84
AB  - This study evaluated the efficacy and safety of use of the Angio-Seal vascular 
      closure device deployment for early ambulation (2 h) after elective percutaneous 
      coronary intervention in 143 consecutive patients receiving either intravenous 
      low-dose enoxaparin (0.5 mg/kg) or unfractionated heparin (UFH). The initial 
      success rate of Angio-Seal(trade mark) deployment was 98.6%, with no significant 
      difference between the UFH group (98.9%) and the enoxaparin group (98.0%). 
      In-hospital and clinic outcomes were evaluated in the 141 patients with 
      successful Angio-Seal deployment. During hospitalization, there were no deaths, 
      myocardial infarction, urgent target vessel revascularization or bleeding events 
      in either group; three patients in the UFH group and none in the enoxaparin group 
      had minor vascular complications (differences not significant). In clinic 
      follow-up, two patients in the UFH group and none in the enoxaparin group had 
      major vascular complications (differences not significant). Routine use of the 
      Angio-Seal(trade mark) for early ambulation in patients receiving intravenous 
      low-dose enoxaparin compared with UFH provides promising efficacy and safety for 
      daily practice.
FAU - Lai, Y-C
AU  - Lai YC
AD  - Division of Cardiology, Department of Internal Medicine, Min-Sheng General 
      Hospital, Taoyuan, Taiwan.
FAU - Kao, H-L
AU  - Kao HL
FAU - Lin, Y-H
AU  - Lin YH
FAU - Lin, M-S
AU  - Lin MS
FAU - Ho, Y-L
AU  - Ho YL
FAU - Chao, C-L
AU  - Chao CL
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PL  - England
TA  - J Int Med Res
JT  - The Journal of international medical research
JID - 0346411
RN  - 0 (Anticoagulants)
RN  - 0 (Enoxaparin)
RN  - 9005-49-6 (Heparin)
SB  - IM
MH  - Aged
MH  - *Angioplasty, Balloon, Coronary/adverse effects/instrumentation
MH  - Anticoagulants/*therapeutic use
MH  - *Early Ambulation
MH  - Enoxaparin/*therapeutic use
MH  - Femoral Artery/surgery
MH  - *Hemostatic Techniques/instrumentation
MH  - Heparin/analogs & derivatives/therapeutic use
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Treatment Outcome
EDAT- 2008/10/04 09:00
MHDA- 2008/10/28 09:00
CRDT- 2008/10/04 09:00
PHST- 2008/10/04 09:00 [pubmed]
PHST- 2008/10/28 09:00 [medline]
PHST- 2008/10/04 09:00 [entrez]
AID - 10.1177/147323000803600527 [doi]
PST - ppublish
SO  - J Int Med Res. 2008 Sep-Oct;36(5):1077-84. doi: 10.1177/147323000803600527.